Bienville Capital Management’s GoodRx Holdings GDRX Stock Holding History

Bienville Capital Management’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-80,800	Closed	-$478K	–	120
2022 Q2	$478K	Buy	+80,800	New	+$899K	0.23%	79
2021 Q4	–	Sell	-8,500	Closed	-$349K	–	100
2021 Q3	$349K	Hold	8,500	–	–	0.2%	75
2021 Q2	$306K	Sell	8,500 -155,671	-95%	-$5.74M	0.03%	115
2021 Q1	$6.41M	Buy	164,171 +20,671	+14%	+$930K	0.81%	22
2020 Q4	$5.79M	Buy	+143,500	New	+$6.59M	0.59%	25

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Bienville Capital Management's GDRX Position: Q3 2022 in Review

Bienville Capital Management sold out of GoodRx Holdings (GDRX) in Q3 2022, closing a stake of 80,800 shares — an estimated $478K sold.

Bienville Capital Management first reported a position in GDRX in Q4 2020 and held it in 5 quarters. The position peaked at $6.41M in Q1 2021. 180 funds tracked by Wall St. Rank hold GDRX as of Q3 2022.

Bienville Capital Management reported no remaining GoodRx Holdings position as of Q3 2022 after selling out during the quarter.
Bienville Capital Management sold 80,800 GoodRx Holdings shares in Q3 2022, an estimated $478K.
Bienville Capital Management first reported a position in GoodRx Holdings in Q4 2020 and held it in 5 quarters.
Bienville Capital Management's GoodRx Holdings position peaked at $6.41M in Q1 2021.
180 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2022.

Based on Bienville Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.